As of November 7, 2026, Elanco Animal Health Inc is a publicly traded company (NYSE: ELAN); its largest reported holder is Dodge & Cox, with 13.9% on Schedule 13G/A of May 14, 2026, then Fidelity (FMR) (13.3%). The largest insider holding is Jeffrey N. Simmons, the chief executive and president, with 2,223,869 shares (0.44% of shares outstanding), per Form 4 of May 19, 2026 (Schedule 13G/A, May 14, 2026).
Is this your company?
About to sign with, pay or invest in Elanco Animal Health Inc? See the free Snapshot first.
Free to see. No signup.
Is Elanco Animal Health Inc a real, registered company?
- Elanco Animal Health Inc files with the SEC under CIK 1739104 (its SEC filings).
- Its shares are listed under the ticker ELAN on NYSE (SEC company record).
- business address in Indianapolis, Indiana, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under ELANCO ANIMAL HEALTH INC in our court records and SEC 8-K records (as of 2026-11-07).
- Layoffs: 1 exit or restructuring plan reported on Form 8-K, Item 2.05 (latest filed 2025-12-09, about 300 jobs).
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Fidelity (FMR) (filed 2026-11-05).
Who are Elanco Animal Health Inc's owners and officers?
Elanco Animal Health Inc: business address in Indianapolis, Indiana; industry Pharmaceutical Preparations (Schedule 13G/A, 2026-11-05).
| Report | Holder | Share |
|---|---|---|
| Schedule 13G/A, 2026-11-05 | Fmr LLC | 13.3% |
| Schedule 13G, 2026-07-14 | Dimensional Fund Advisors LP | 5.1% |
| Schedule 13G/A, 2026-05-14 | Dodge & Cox | 13.9% |
| Schedule 13G/A, 2026-05-13 | Primecap Management Co/Ca/ | 9.22% |
| Schedule 13G, 2026-04-29 | Vanguard Capital Management | 5.25% |
| Schedule 13G/A, 2026-04-09 | Dimensional Fund Advisors LP | 4.9% |
| Schedule 13G/A, 2026-03-26 | The Vanguard Group | 0% |
| Schedule 13G/A, 2026-02-13 | Dodge & Cox | 15.9% |
| Schedule 13G/A, 2026-02-05 | Fmr LLC | 10.5% |
| Schedule 13G, 2026-01-21 | Dimensional Fund Advisors LP | 5% |
| Schedule 13G, 2025-11-14 | T. Rowe Price Investment Management, Inc. | 6.4% |
| Schedule 13G, 2025-10-17 | Blackrock, Inc. | 8.9% |
Questions about who owns Elanco Animal Health Inc
Who owns Elanco Animal Health Inc?
On this page, 7 holders' latest ownership filings report 5% or more of Elanco Animal Health Inc: Dodge & Cox (13.9%, Schedule 13G/A, filed 2026-05-14), Fmr LLC (13.3%, Schedule 13G/A, filed 2026-11-05), Primecap Management Co/Ca/ (9.22%, Schedule 13G/A, filed 2026-05-13), Blackrock, Inc. (8.9%, Schedule 13G, filed 2025-10-17) and T. Rowe Price Investment Management, Inc. (6.4%, Schedule 13G, filed 2025-11-14); 2 more are listed above.
Who are the largest shareholders of Elanco Animal Health Inc?
By the share each holder's latest filing reports, the largest holders of Elanco Animal Health Inc on this page are Dodge & Cox (13.9%), Fmr LLC (13.3%) and Primecap Management Co/Ca/ (9.22%).
When did Dodge & Cox buy into Elanco Animal Health Inc?
The filings give report dates, not purchase dates. The earliest filing from Dodge & Cox on this page is the Schedule 13G/A, filed 2026-02-13, reporting 15.9%; its latest, Schedule 13G/A filed 2026-05-14, reports 13.9%. That earliest filing is itself an amendment, which updates an earlier report.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 12 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Want the whole picture on Elanco Animal Health Inc?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Elanco Animal Health Inc: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Elanco Animal Health Inc covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
19 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Which insiders own Elanco Animal Health Inc shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- , the chief executive and president: 2,223,869 shares (0.44% of shares outstanding), 2,051,898 held directly and 171,971 indirectly (Form 4, 2026-05-19).
- Todd S. Young: 369,839 shares (0.07% of shares outstanding), 200,969 held directly and 168,870 indirectly (Form 4, 2025-03-05).
- Cabral Ramiro Martin: 283,874 shares (0.06% of shares outstanding) (Form 4, 2026-03-05).
- de Brabander Ellen: 280,821 shares (0.06% of shares outstanding) (Form 4, 2026-04-07).
- , a director: 277,371 shares (0.06% of shares outstanding), 111,451 held directly and 165,920 indirectly (Form 4, 2026-05-26).
Shares outstanding: 499,827,067 as of 2026-11-04, from the company's latest SEC cover page.
How much has Elanco Animal Health Inc raised?
No fundraising or offering filing from Elanco Animal Health Inc is on file with us.
Red flags found
1 exit or restructuring plan on Form 8-K (latest Form 8-K, 2025-12-09).
Keep reading
More on Elanco Animal Health Inc and the records around it.
Elanco Animal Health Inc elsewhere on the record
- 5%+ stake filings Nov 2026
- Layoff notices Dec 2025
Companies that share a holder
- PRIMECAP MANAGEMENT CO/CA/ also filed stake reports on 24 other companies: Xencor Inc (Nov 2026), GRAIL, Inc. (Nov 2026), MARKETAXESS HOLDINGS INC (Nov 2026)
- Dodge & Cox also filed stake reports on 36 other companies: Charter Communications, Inc. (Aug 2026), SUN COMMUNITIES, INC (Aug 2026), TransUnion (Jun 2026)
- T. Rowe Price Investment Management, Inc. also filed stake reports on 167 other companies: CABALETTA BIO INC (Nov 2026), MADISON SQUARE GARDEN SPORTS CORP (Nov 2026), MSG RANGERS CORP (Nov 2026)
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/elanco-animal-health